Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54
United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jayne B. Hart
28 Feb 2022
Chief People Officer
Sold after exercise
3,500
$25.00
$87.50K
Jayne B. Hart
28 Feb 2022
Chief People Officer
Sold after exercise
7,000
$25.00
$175.00K
Jayne B. Hart
17 Sep 2021
Chief People Officer
Sold after exercise
2,966
$33.72
$100.01K
Jayne B. Hart
17 Sep 2021
Chief People Officer
Sold after exercise
64,480
$33.72
$2.17M
Jerry S Lanchbury
24 Aug 2021
Chief Scientific Officer
Sold after exercise
30,000
$35.57
$1.07M
Jerry S Lanchbury
23 Aug 2021
Chief Scientific Officer
Sold after exercise
40,000
$35.07
$1.40M
Jerry S Lanchbury
23 Aug 2021
Chief Scientific Officer
Sold after exercise
10,000
$35.57
$355.70K
S. Louise Phanstiel
5 Aug 2021
Director
Sold after exercise
47,881
$35.04
$1.68M
Jerry S Lanchbury
5 Aug 2021
Chief Scientific Officer
Sold after exercise
28,225
$35.57
$1.00M
Jerry S Lanchbury
4 Aug 2021
Chief Scientific Officer
Sold after exercise
11,775
$35.57
$418.86K
Jerry S Lanchbury
4 Aug 2021
Chief Scientific Officer
Sold after exercise
38,225
$35.24
$1.35M
Dennis Langer
3 Aug 2021
Director
Sold after exercise
30,000
$34.75
$1.04M
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
4,170
$34.00
$141.78K
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
27,830
$34.00
$946.22K
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
1,775
$35.07
$62.25K
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
16,225
$33.99
$551.49K
Jerry S Lanchbury
13 Jul 2021
Chief Scientific Officer
Sold after exercise
40,000
$33.74
$1.35M
Jerry S Lanchbury
13 Jul 2021
Chief Scientific Officer
Sold after exercise
3,295
$33.69
$111.01K
Jerry S Lanchbury
12 Jul 2021
Chief Scientific Officer
Sold after exercise
13,295
$33.55
$446.08K
Jerry S Lanchbury
12 Jul 2021
Chief Scientific Officer
Sold after exercise
36,705
$33.55
$1.23M
Jerry S Lanchbury
9 Jul 2021
Chief Scientific Officer
Sold after exercise
17,692
$32.47
$574.46K
Jerry S Lanchbury
9 Jul 2021
Chief Scientific Officer
Sold after exercise
5,603
$32.29
$180.92K
Jerry S Lanchbury
9 Jul 2021
Chief Scientific Officer
Sold after exercise
26,705
$32.79
$875.66K
Jerry S Lanchbury
7 Jul 2021
Chief Scientific Officer
Sold after exercise
1,884
$31.99
$60.27K
Jerry S Lanchbury
7 Jul 2021
Chief Scientific Officer
Sold after exercise
30,424
$32.29
$982.39K
Jerry S Lanchbury
28 Jun 2021
Chief Scientific Officer
Sold after exercise
948
$32.49
$30.80K
Jerry S Lanchbury
28 Jun 2021
Chief Scientific Officer
Sold after exercise
1,891
$32.23
$60.95K
Jerry S Lanchbury
28 Jun 2021
Chief Scientific Officer
Sold after exercise
3,973
$32.43
$128.85K
Jerry S Lanchbury
25 Jun 2021
Chief Scientific Officer
Sold after exercise
33,372
$31.61
$1.06M
Jerry S Lanchbury
25 Jun 2021
Chief Scientific Officer
Sold after exercise
28,640
$31.97
$915.62K
Jerry S Lanchbury
25 Jun 2021
Chief Scientific Officer
Sold after exercise
21,360
$32.47
$693.56K
Jerry S Lanchbury
4 May 2021
Chief Scientific Officer
Sold after exercise
19,360
$31.97
$618.95K
Jerry S Lanchbury
27 Apr 2021
Chief Scientific Officer
Sold after exercise
40,000
$31.47
$1.26M
Jayne B. Hart
29 Mar 2021
Chief People Officer
Sold after exercise
8,034
$30.00
$241.02K
Jayne B. Hart
29 Mar 2021
Chief People Officer
Sold after exercise
21,966
$30.00
$658.98K
Jayne B. Hart
29 Mar 2021
Chief People Officer
Sold after exercise
28,000
$30.00
$840.00K
Jerry S Lanchbury
16 Feb 2021
Chief Scientific Officer
Sold after exercise
5,555
$29.71
$165.06K
Jerry S Lanchbury
16 Feb 2021
Chief Scientific Officer
Sold after exercise
74,445
$29.71
$2.21M
Gary A. King
1 Aug 2019
Exec. VP International Ops
Sold after exercise
20,000
$39.44
$788.81K
Gary A. King
1 Aug 2019
Exec. VP International Ops
Sold after exercise
10,000
$43.48
$434.82K
Gary A. King
1 Aug 2019
Exec. VP International Ops
Sold after exercise
30,000
$46.19
$1.39M
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
3,862
$44.00
$169.93K
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
58,138
$44.00
$2.56M
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
4,328
$44.00
$190.43K
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
70,672
$44.00
$3.11M
Mark Christopher Capone
11 Jul 2018
President & C.E.O.
Sold after exercise
2,346
$41.00
$96.19K
Mark Christopher Capone
11 Jul 2018
President & C.E.O.
Sold after exercise
77,654
$41.00
$3.18M
Richard M Marsh
11 Jul 2018
E.V.P., General Counsel
Sold after exercise
40,000
$42.02
$1.68M
Richard M Marsh
11 Jul 2018
E.V.P., General Counsel
Sold after exercise
30,672
$44.00
$1.35M
John T Henderson
11 Jul 2018
Director
Sold after exercise
10,000
$40.17
$401.70K
John T Henderson
11 Jul 2018
Director
Sold after exercise
10,000
$42.01
$420.09K
John T Henderson
11 Jul 2018
Director
Sold after exercise
10,000
$44.00
$440.00K
Jerry S Lanchbury
11 Jul 2018
Chief Scientific Officer
Sold after exercise
3,861
$43.34
$167.34K
Jerry S Lanchbury
11 Jul 2018
Chief Scientific Officer
Sold after exercise
46,139
$43.34
$2.00M
Richard M Marsh
18 Jun 2018
E.V.P., General Counsel
Sold after exercise
33,000
$40.00
$1.32M
Jerry S Lanchbury
18 Jun 2018
Chief Scientific Officer
Sold after exercise
2,346
$40.12
$94.12K
Jerry S Lanchbury
18 Jun 2018
Chief Scientific Officer
Sold after exercise
57,654
$40.12
$2.31M
Dennis Langer
8 Jun 2018
Director
Sold after exercise
13,664
$39.35
$537.68K
Dennis Langer
7 Jun 2018
Director
Sold after exercise
3,096
$39.35
$121.83K
Walter Phd Gilbert
6 Jun 2018
Director
Sold after exercise
1,189
$39.80
$47.32K
Dennis Langer
6 Jun 2018
Director
Sold after exercise
3,609
$39.37
$142.09K
Dennis Langer
5 Jun 2018
Director
Sold after exercise
1,227
$39.90
$48.96K
Walter Phd Gilbert
5 Jun 2018
Director
Sold after exercise
28,811
$39.68
$1.14M
Dennis Langer
4 Jun 2018
Director
Sold after exercise
8,404
$39.90
$335.32K
Dennis Langer
4 Jun 2018
Director
Sold after exercise
10,000
$39.90
$399.00K
Dennis Langer
1 Jun 2018
Director
Sold after exercise
30,000
$38.90
$1.17M
Dennis Langer
30 May 2018
Director
Sold after exercise
10,000
$37.92
$379.25K
Richard M Marsh
30 May 2018
E.V.P., General Counsel
Sold after exercise
33,139
$38.00
$1.26M
Mark Christopher Capone
30 May 2018
President & C.E.O.
Sold after exercise
90,000
$38.00
$3.42M
Dennis Langer
21 May 2018
Director
Sold after exercise
10,000
$35.90
$359.00K
Richard M Marsh
22 Jan 2018
E.V.P., General Counsel
Sold after exercise
37,654
$40.25
$1.52M
Gary A. King
22 Jan 2018
Exec. VP International Ops
Sold after exercise
4,445
$39.03
$173.49K
Gary A. King
22 Jan 2018
Exec. VP International Ops
Sold after exercise
30,000
$39.77
$1.19M
Gary A. King
18 Jan 2018
Exec. VP International Ops
Sold after exercise
3,120
$38.12
$118.93K
Richard M Marsh
18 Jan 2018
E.V.P., General Counsel
Sold after exercise
40,000
$38.25
$1.53M
John T Henderson
1 Sep 2017
Director
Sold after exercise
10,000
$30.30
$302.98K
John T Henderson
1 Sep 2017
Director
Sold after exercise
10,000
$30.30
$303.00K
John T Henderson
1 Sep 2017
Director
Sold after exercise
10,000
$30.31
$303.06K

What was left out

Form 4 filings counted 546
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 78
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 15,234,074
Sales filed before the plan box existed 26
History held since 18 Oct 2006